FibroBiologics Reports Preclinical Data Showing FSdC Spheroids Best Preserve Disc Height In Rabbit Degenerative Disc Disease Model
FSdC Spheroids Preserved Disc Height Better Than Any Other Fibroblast-Based Approach Tested in a 12-Week Rabbit Model of Degenerative Disc DiseaseHOUSTON, Oct. 19, 2026 /PRNewswire/ -- FibroBiologics, Inc. (NASDAQ:FBLG)
FibroBiologics tested a new treatment for damaged spinal discs in rabbits. The treatment worked better than similar ones, so the company may be on a promising path.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.